Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

1
Player Avatar nostra2006 (< 20) Submitted: 1/1/2010 10:33:05 PM : Outperform Start Price: $13.20 LGND Score: -20.06

outperform

Featured Broker Partners


Advertisement